Found: 1
Select item for more details and to access through your institution.
EGF+61 A>G polymorphism does not predict response to first‐generation EGFR tyrosine kinase inhibitors in lung cancer patients.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 2987, doi. 10.1111/1759-7714.13628
- By:
- Publication type:
- Article